Intelligence Platform
Patents
Browse 570 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11203596
Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for
granted patentUS 11191842
Injectable thermoresponsive polyelectrolytes
granted patentUS 11185674
Targeted delivery of biologic therapeutic agents
granted patentUS 11179494
Collagenous tissue repair device
granted patentUS 11174288
Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-r
granted patentUS 11174514
Methods, kits, and devices utilizing HTR2C polymorphisms for diagnosing, prognosing, and t
granted patentUS 11160851
Peptide conjugated particles
granted patentUS 11161876
Anti-inflammatory nanofibers
granted patentUS 11149020
MAP kinase modulators and uses thereof
granted patentUS 11142504
Substituted heterocycles as c-MYC targeting agents
granted patentUS 11135236
Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiotoxicity
granted patentUS 11129881
Peptide conjugated particles
granted patentUS 11129790
Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conj
granted patentUS 11125741
Compositions and methods for the detection of zinc
granted patentUS 11124612
Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic mo
granted patentUS 11118180
Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, vari
granted patentUS 11104901
Brush polymer-assisted compaction of oligonucleotides
granted patentUS 11078471
Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)
granted patentUS 11077057
Polymer-grafted nanobins
granted patentUS 11071727
Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (
granted patentUS 11065299
Compositions and methods for modulation of immune response
granted patentUS 11066444
BMP-2-binding peptide amphiphile nanofibers
granted patentUS 11065262
Topical treatment of wounds with statins and cholesterol for scar reduction
granted patentUS 11059878
Therapeutic targeting of SET1B/compass pathway for treating cancers
granted